Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non–Small Cell Lung Cancer
Katelyn M. Atkins(Brigham and Women's Hospital), Raymond H. Mak(Brigham and Women's Hospital), Nayan Lamba(Harvard University), Udo Hoffmann(Massachusetts General Hospital), Danielle S. Bitterman(Brigham and Women's Hospital), Tafadzwa L. Chaunzwa(Dana-Farber Cancer Institute), Jeremy S. Bredfeldt(Brigham and Women's Hospital), Bhupendra Rawal(Harvard University), David Kozono(Dana-Farber Cancer Institute), Elizabeth H. Baldini(Dana-Farber Cancer Institute), Hugo J.W.L. Aerts(Maastro Clinic), Christopher L. Williams(Dana-Farber Cancer Institute), Anju Nohria(Brigham and Women's Hospital)
Cited by 225
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
|Circulation|2020|535
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482
Arterial Inflammation in Patients With HIV
|JAMA|2012|460